Long-term Efficacy and Safety of Recombinant Interferon Alpha-2 vs. Hydroxyurea in Polycythemia Vera: Preliminary Results From the Three-Year Analysis of the DALIAH Trial – A Randomized Controlled Phase III Clinical Trial.

Trine Alma Knudsen, Dennis Lund Hansen, Lukas Frans Ocias, Ole Weiss Bjerrum, Mette Brabrand, Daniel El Fassi, Mikael Frederiksen, Lasse Kjær, Thomas Kielsgaard Kristensen, Torben Kruse, Hans Torben Mourits-Andersen, Peter Møller, Ulrik Malthe Overgaard, Marianne Tang Severinsen, Vibe Skov, Jesper Stentoft, Jørn Starklint, Karin de Stricker, Mads Thomassen, Thomas Stauffer LarsenHans Carl Hasselbalch

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

OriginalsprogEngelsk
TidsskriftBlood
Vol/bind132
Udgave nummerSuppl. 1
ISSN0006-4971
StatusUdgivet - nov. 2018
BegivenhedAmerican Society of Hematology: 60th Annual Meeting (ASH) - San Diego, USA
Varighed: 29. nov. 20184. dec. 2018

Konference

KonferenceAmerican Society of Hematology: 60th Annual Meeting (ASH)
LandUSA
BySan Diego
Periode29/11/201804/12/2018

Citer dette

Knudsen, Trine Alma ; Lund Hansen, Dennis ; Ocias, Lukas Frans ; Weiss Bjerrum, Ole ; Brabrand, Mette ; El Fassi, Daniel ; Frederiksen, Mikael ; Kjær, Lasse ; Kielsgaard Kristensen, Thomas ; Kruse, Torben ; Mourits-Andersen, Hans Torben ; Møller, Peter ; Overgaard, Ulrik Malthe ; Severinsen, Marianne Tang ; Skov, Vibe ; Stentoft, Jesper ; Starklint, Jørn ; de Stricker, Karin ; Thomassen, Mads ; Larsen, Thomas Stauffer ; Hasselbalch, Hans Carl . / Long-term Efficacy and Safety of Recombinant Interferon Alpha-2 vs. Hydroxyurea in Polycythemia Vera: Preliminary Results From the Three-Year Analysis of the DALIAH Trial – A Randomized Controlled Phase III Clinical Trial. I: Blood. 2018 ; Bind 132, Nr. Suppl. 1.
@article{e3179d20b94b4c839ed231301298e4e6,
title = "Long-term Efficacy and Safety of Recombinant Interferon Alpha-2 vs. Hydroxyurea in Polycythemia Vera: Preliminary Results From the Three-Year Analysis of the DALIAH Trial – A Randomized Controlled Phase III Clinical Trial.",
author = "Knudsen, {Trine Alma} and {Lund Hansen}, Dennis and Ocias, {Lukas Frans} and {Weiss Bjerrum}, Ole and Mette Brabrand and {El Fassi}, Daniel and Mikael Frederiksen and Lasse Kj{\ae}r and {Kielsgaard Kristensen}, Thomas and Torben Kruse and Mourits-Andersen, {Hans Torben} and Peter M{\o}ller and Overgaard, {Ulrik Malthe} and Severinsen, {Marianne Tang} and Vibe Skov and Jesper Stentoft and J{\o}rn Starklint and {de Stricker}, Karin and Mads Thomassen and Larsen, {Thomas Stauffer} and Hasselbalch, {Hans Carl}",
year = "2018",
month = "11",
language = "English",
volume = "132",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "Suppl. 1",

}

Knudsen, TA, Lund Hansen, D, Ocias, LF, Weiss Bjerrum, O, Brabrand, M, El Fassi, D, Frederiksen, M, Kjær, L, Kielsgaard Kristensen, T, Kruse, T, Mourits-Andersen, HT, Møller, P, Overgaard, UM, Severinsen, MT, Skov, V, Stentoft, J, Starklint, J, de Stricker, K, Thomassen, M, Larsen, TS & Hasselbalch, HC 2018, 'Long-term Efficacy and Safety of Recombinant Interferon Alpha-2 vs. Hydroxyurea in Polycythemia Vera: Preliminary Results From the Three-Year Analysis of the DALIAH Trial – A Randomized Controlled Phase III Clinical Trial.', Blood, bind 132, nr. Suppl. 1.

Long-term Efficacy and Safety of Recombinant Interferon Alpha-2 vs. Hydroxyurea in Polycythemia Vera: Preliminary Results From the Three-Year Analysis of the DALIAH Trial – A Randomized Controlled Phase III Clinical Trial. / Knudsen, Trine Alma; Lund Hansen, Dennis; Ocias, Lukas Frans; Weiss Bjerrum, Ole; Brabrand, Mette; El Fassi, Daniel; Frederiksen, Mikael; Kjær, Lasse; Kielsgaard Kristensen, Thomas; Kruse, Torben ; Mourits-Andersen, Hans Torben ; Møller, Peter; Overgaard, Ulrik Malthe ; Severinsen, Marianne Tang; Skov, Vibe; Stentoft, Jesper; Starklint, Jørn; de Stricker, Karin ; Thomassen, Mads; Larsen, Thomas Stauffer; Hasselbalch, Hans Carl .

I: Blood, Bind 132, Nr. Suppl. 1, 11.2018.

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

TY - ABST

T1 - Long-term Efficacy and Safety of Recombinant Interferon Alpha-2 vs. Hydroxyurea in Polycythemia Vera: Preliminary Results From the Three-Year Analysis of the DALIAH Trial – A Randomized Controlled Phase III Clinical Trial.

AU - Knudsen, Trine Alma

AU - Lund Hansen, Dennis

AU - Ocias, Lukas Frans

AU - Weiss Bjerrum, Ole

AU - Brabrand, Mette

AU - El Fassi, Daniel

AU - Frederiksen, Mikael

AU - Kjær, Lasse

AU - Kielsgaard Kristensen, Thomas

AU - Kruse, Torben

AU - Mourits-Andersen, Hans Torben

AU - Møller, Peter

AU - Overgaard, Ulrik Malthe

AU - Severinsen, Marianne Tang

AU - Skov, Vibe

AU - Stentoft, Jesper

AU - Starklint, Jørn

AU - de Stricker, Karin

AU - Thomassen, Mads

AU - Larsen, Thomas Stauffer

AU - Hasselbalch, Hans Carl

PY - 2018/11

Y1 - 2018/11

M3 - Conference abstract in journal

VL - 132

JO - Blood

JF - Blood

SN - 0006-4971

IS - Suppl. 1

ER -